Company: THC
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0000070318-25-000039
Chunk: 56

Company: TENET HEALTHCARE CORP
Filing Date: 2025-07-30
Form: 10-Q
Item: Part I, Item 1
Chunk 56
---
 By segment:Hospital Operations$10 $15 $19 $30 Ambulatory Care14 14 24 26 Total impairment and restructuring charges, and acquisition-related costs$24 $29 $43 $56 

Restructuring charges during the three months ended June 30, 2025 included $4 million related to the transition of various administrative functions to our GBC, $3 million of contract and lease termination fees, $2 million of employee severance costs and $1 million of other restructuring costs. During the three months ended June 30, 2024, restructuring charges consisted of $7 million of legal costs related to the sale of certain businesses, $5 million of employee severance costs, $2 million related to the transition of various administrative functions to our GBC and $4 million of other restructuring costs.

Restructuring charges during the six months ended June 30, 2025 included $10 million of contract and lease termination fees, $7 million related to the transition of various administrative functions to our GBC, $4 million of employee severance costs, $3 million of legal costs related to the sale of certain businesses and $1 million of other restructuring costs. Restructuring charges for the six months ended June 30, 2024 consisted of $14 million of legal costs related to the sale of certain businesses, $6 million of employee severance costs, $5 million related to the transition of various administrative functions to our GBC and $7 million of other restructuring costs.

Acquisition-related costs consisted entirely of transaction costs for all of the periods in the table above.

Litigation and Investigation Costs

Litigation and investigation costs totaled $28 million and $45 million during the three and six months ended June 30, 2025, respectively, and $5 million and $9 million for the same periods in 2024, respectively.

Net Losses (Gains) on Sales, Consolidation and Deconsolidation of Facilities

We recorded net losses from the sale, consolidation and deconsolidation of facilities totaling $38 million and $16 million during the three and six months ended June 30, 2025, respectively. During the three months ended June 30, 2025, we recorded net losses of $42 million associated with the consolidation of certain facilities, partially offset by net gains of $4 million